Associations of statin use with glycaemic traits and incident type 2 diabetes
Typ-2-Diabetes: Höheres Progressionsrisiko unter Statin-Therapie?
Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study | Journal of the American Heart Association
Studie: Statine fördern Fortschreiten eines Typ-2-Diabetes
Statins Linked With Type 2 Diabetes Progression, Study Suggests | Everyday Health
Risk of incident diabetes among patients treated with statins: population based study | The BMJ
Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients - Suyog Sindhu, Hemant Kumar Singh, Mohammad Tariq Salman, Jalees Fatima, Vinod Kumar
IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights
No effects of atorvastatin (10 mg/d or 80 mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study - ScienceDirect
Statins and Risk of New-Onset Diabetes Mellitus | Circulation
Understanding How Statins Prevent Cardiovascular Disease but Increase Diabetes Risk | Stanford Cardiovascular Institute | Stanford Medicine
Statin patterns and associated factors in type 2 diabetes | DMSO
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial - The Lancet
Association between statin treatment and new-onset diabetes mellitus: a population based case–control study | Diabetology & Metabolic Syndrome | Full Text
Senkung der kardiovaskulären Ereignisse mit Atorvastatin bei Patienten mit Typ-2-Diabetes
LDL Cholesterol and Diabetes | CRESTOR® (rosuvastatin calcium)
Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology
Slide Source: Lipids Online Slide Library Collaborative Atorvastatin Diabetes Study (CARDS) Type 2 diabetes mellitus Men and women. - ppt download
Biomedicines | Free Full-Text | Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study
Statins in Diabetes Treatment: Risks and Benefits - GoodRx
Statintherapie erhöht Diabetesrisiko bei Hoch-Risiko-Gruppen
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis | NEJM
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial - The Lancet
View of Management of lipids in adults with diabetes mellitus and nephropathy and/or chronic kidney disease: summary of joint guidance from the Association of British Clinical Diabetologists (ABCD) and the Renal Association (
Behandlungsoptionen bei Statin-assoziierten Muskelbeschwerden
Statin treatment and new-onset diabetes: A review of proposed mechanisms - ScienceDirect
